Alain Bernard

ORCID: 0000-0002-5367-0097
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Pleural and Pulmonary Diseases
  • Lung Cancer Treatments and Mutations
  • Gastric Cancer Management and Outcomes
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Esophageal Cancer Research and Treatment
  • Lymphoma Diagnosis and Treatment
  • Viral Infectious Diseases and Gene Expression in Insects
  • Glycosylation and Glycoproteins Research
  • Complement system in diseases
  • Blood groups and transfusion
  • Cardiac, Anesthesia and Surgical Outcomes
  • Acute Lymphoblastic Leukemia research
  • Cell death mechanisms and regulation
  • Acute Myeloid Leukemia Research
  • Pancreatic and Hepatic Oncology Research
  • Immune Response and Inflammation
  • Sarcoma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging

Maison des Sciences de l’Homme de Dijon
2011-2025

Université de Bourgogne
1997-2024

Centre Hospitalier Universitaire Dijon Bourgogne
2015-2024

Laboratoire des Sciences du Numérique de Nantes
2023

Nantes Université
2023

Centre de recherche Translationnelle en Médecine moléculaire
2018

The Affiliated Yongchuan Hospital of Chongqing Medical University
2017

Chongqing Medical University
2017

Inserm
2003-2016

Centre Hospitalier Universitaire de Nice
1999-2016

Proteins of the Bcl-2 family are intracellular membrane-associated proteins that regulate programmed cell death (apoptosis) either positively or negatively by as yet unknown mechanisms. Bax, a pro-apoptotic member family, was shown to form channels in lipid membranes. Bax triggered release liposome-encapsulated carboxyfluorescein at both neutral and acidic pH. At physiological pH, could be blocked Bcl-2. Bcl-2, contrast, pH only. In planar bilayers, formed pH- voltage-dependent...

10.1126/science.277.5324.370 article EN Science 1997-07-18

Children with B cell non-Hodgkin's lymphoma who have not relapsed 1 year after diagnosis and treatment are generally cured. We report here the results of in 114 children all had a minimum follow-up 20 months. The protocol LMB 0281 from French Pediatric Oncology Society was used. This nine-drug intensive-pulsed chemotherapy based on high-dose cyclophosphamide, methotrexate (HD MTX), cytosine arabinoside (ara-C) continuous infusion. CNS prophylaxis only. No local irradiation performed....

10.1200/jco.1986.4.8.1219 article EN Journal of Clinical Oncology 1986-08-01

We obtained a monoclonal antibody, A50, after immunizing Biozzi's high responder strain of mice with T cell chronic lymphocytic leukemia (T-CLL) cells. A50 recognized an antigen present on the surface B cells from many patients and lineage any subject we tested. could not find this either normal or other non-T malignancies. On cells, was subpopulation thymus most peripheral The T-CLL, Sézary's disease, subset o lymphoma. seemed to belong complex set antigenic determinants that had defined...

10.1084/jem.152.1.229 article EN The Journal of Experimental Medicine 1980-07-01

CD47 on the surface of T cells was shown in vitro to mediate either cell activation or, presence high amounts thrombospondin (TSP), apoptosis. We report here that CD47-deficient mice, as well TSP-1 or TSP-2-deficient sustain oxazolone-induced inflammation for more than four days, whereas wild-type mice reduce within 48 h. observe prolonged CD47-, TSP-1-, is accompanied by a local deficiency Finally, we show upon normal increase expression proapoptotic Bcl-2 family member BNIP3...

10.4049/jimmunol.178.9.5930 article EN The Journal of Immunology 2007-05-01

Nutritional assessment is not included yet as a major recommendation in lung cancer guidelines. The purpose of this study was thus to assess the influence on surgical outcome nutritional status patients with primary undergoing lobectomy. We queried Epithor, national clinical database French Society Thoracic and Cardiovascular Surgery, identified retrospective cohort 19 635 having undergone lobectomy for years 2005–11. Their categorized according WHO definition: underweight (BMI < 18.5): 857...

10.1093/ejcts/ezt452 article EN European Journal of Cardio-Thoracic Surgery 2013-09-23

One set of antigens is common to some chronic lymphocytic leukemia (CLL) cells bearing surface immunoglobulins (Ig) and normal T cells. Proliferating from thirty-eight patients were studied with four antisera recognizing human but not B These raised in rabbits against (a) Sezary cells, (b) blood lymphocytes a patient sex-linked agammaglobulinemia, (c) lymphoblasts (d) thymus In CLL cases, the expressed receptor for sheep erythrocytes lacked Ig. Cells thirty-four cases bore monoclonal Ig did...

10.1002/eji.1830081214 article EN European Journal of Immunology 1978-12-01

CD40 ligand (CD40L) is expressed on the surface of activated CD4+ T cells, basophils, and mast cells. Binding C40L to its receptor, CD40, B cells stimulates cell proliferation, adhesion differentiation. A preparation soluble, recombinant CD40L (Tyr-45 Leu-261), containing full-length 29-kDa protein two smaller fragments 18 14 kDa, has been shown induce differentiation derived either from normal donors or patients with X-linked hyper-IgM syndrome (Durandy, A., Schiff, C., Bonnefoy, J.-Y.,...

10.1074/jbc.270.13.7025 article EN cc-by Journal of Biological Chemistry 1995-03-01

Abstract E2/CD99 is a 32-kDa transmembrane molecule that does not belong to any known family of proteins. It appears regulate adhesion properties T cells as previously reported, in particular, the induction homotypic CD4+ CD8+ thymocytes. Apoptosis induced via displays characteristic morphologic features, but includes early mitochondrial alterations and phosphatidylserine exposure at outer leaflet plasma membrane. followed by detectable DNA fragmentation, its time course much longer than...

10.4049/jimmunol.158.6.2543 article EN The Journal of Immunology 1997-03-15

Anti-D66 is a monoclonal antibody able to inhibit E-rosette formation of T cells both at 4 degrees C and 37 degree but that does not cell rosette with neuraminidase or 2-amino-ethylisothiouronium bromide (AET)-pretreated E. As demonstrated by capping experiments, it defines an epitope, D66, directly involved in formation. D66 distinct from the epitope defined 9.6 because 9.6, previously "pan-T" antibody, inhibits E(AET) no cross-blocking occurred between antibodies fixation. However, are...

10.1084/jem.155.5.1317 article EN The Journal of Experimental Medicine 1982-05-01
Coming Soon ...